A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India

International Journal of Cancer

Volumn 116, Issue 4, 2005, Pages 617-623

  Sankaranarayanan, Rengaswamy ^a   Nene, Bhagwan M ^b   Dinshaw, Ketayun A ^c   Mahe, Cedric ^a   Jayant, Kasturi ^b   Shastri, Surendra S ^c   Malvi, Sylla G ^c   Chinoy, Roshini ^c   Kelkar, Rohini ^c   Budukh, Atul M ^b   Keskar, Vijay ^b   Rajeshwarker, Raghevendra ^b   Muwonge, Richard ^a   Kane, Shubhada ^c   Parkin, Donald Maxwell ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b Nargis Dutt Memorial Cancer Hospital   (India)

^c TATA MEMORIAL HOSPITAL   (India)

Author keywords

Cervical cancer; Cytology; Human papillomavirus testing; Screening; Visual inspection with acetic acid

Indexed keywords

ACETIC ACID; DOXYCYCLINE; METRONIDAZOLE; NITROUS OXIDE; VIRUS DNA;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CLINICAL TRIAL; CLUSTER ANALYSIS; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOTHERAPY; ELECTROSURGERY; FEMALE; FOLLOW UP; GENERAL ANESTHESIA; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; INDIA; LOCAL ANESTHESIA; LOOP ELECTROSURGICAL EXCISION PROCEDURE; MAJOR CLINICAL STUDY; MIDWIFE; PRECANCER; PRIORITY JOURNAL; PUNCH BIOPSY; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; RURAL AREA; TREATMENT OUTCOME; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; UTERINE CERVIX CYTOLOGY; VISUAL INSPECTION WITH ACETIC ACID; WART VIRUS;

ACETIC ACID; ADULT; COST CONTROL; CYTOLOGICAL TECHNIQUES; DNA, VIRAL; FEMALE; HUMANS; INDIA; MASS SCREENING; MIDDLE AGED; PATIENT PARTICIPATION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RURAL POPULATION; UTERINE CERVICAL NEOPLASMS;

EID: 16844367482     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.21050     Document Type: Article

References (27)

1. Parkin DM, Bray FI, Devassa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37:S4-66.
2. Hakama M, Miller AB, Day NE, eds. Screening for cancer of the uterine cervix. IARC Sci Publ 76. Lyon: IARC, 1986.
3. Sankaranarayanan R, Budukh A, Rajkumar R. Effective screening programs for cervical cancer in low- and middle-income developing countries. Bull World Health Organ 2001;79:954-62.
4. Rubles SC, White F, Peruga A. Trends in cervical cancer mortality in the Americas. Bull Pan Am Health Organ 1996;30:290-301.
5. University of Zimbabwe/JHPIEGO Cervical Cancer Project. Visual inspection with acetic acid for cervical cancer screening: test qualities in a primary-care setting. Lancet 1999;353:869-73.
6. Belinson JL, Pretorius RG, Zhang WH, Wu LY, Qiao YL, Elson P. Cervical cancer screening by simple visual inspection after acetic acid. Obstet Gynecol 2001;98:441-4.
7. Sankaranarayanan R, Basu P, Wesley R, Mahe C, Keita N, Gombe Mbalwa CC, Sharma R, Dolo A, Shastri SS, Nacoulma M, Nayama M, Thara S, et al., for the IARC Multicentre Study Group on Cervical Cancer Early Detection. Accuracy of visual screening for cervical neoplasia: results from an IARC multicentre study in India and Africa. Int J Cancer 2004;110:907-13.
8. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC monographs on the evaluation of carcinogenic risks to humans, vol 64. Lyon: IARC, 1995.
9. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65.
10. Franco EL. Primary screening of cervical cancer with human papillomavirus tests. J Natl Cancer Inst Monogr 2003;31:89-96.
11. Jayant K, Rao RS, Nene BM, Dale PS. India, Barshi, Paranda and Bhum cancer registry. In: Parkin DM, Whelan SL, Young J Jr, Raymond L, eds. Cancer incidence in five continents, vol. VII. IARC Sci Publ 143. Lyon: IARC, 1997, 342-5.
12. Sankaranarayanan R, Wesley R. A practical manual on visual screening for cervical neoplasia. IARC Tech Publ 41. Lyon: IARC, 2003.
13. Kurman RJ, Malkasian GD Jr, Sedis A, Solomon D. From Papanicolaou to Bethesda: the rationale for a new cervical cytologic classification. Obstet Gynecol 1991;77:779-82.
14. Sellors J, Sankaranarayanan R. Colposcopy and treatment of cervical intraepithelial neoplasia: a beginners' manual. IARC non-serial publication. Lyon: IARC, 2003.
15. Richart RM. Natural history of cervical intraepithelial neoplasia. Clin Obstet Gynecol 1968;5:748-84.
16. Tavassoli FA, Devilee P, eds. World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC, 2003.
17. Haves RJ, Bennett S. Sample size calculation for cluster randomized trials. Int J Epidemiol 1999;28:319-26.
18. Wright TC Jr. Cervical cancer screening using visualization techniques. J Natl Cancer Inst Monogr 2003;31:66-71.
19. Sankaranarayanan R, Rajkumar R, Theresa R, Esmy PO, Mahe C, Bagyalakshmi KR, Thara S, Frappart L, Lucas E, Muwonge R, Shanthakumari S, Jeevan D, et al. Initial results from a randomised trial of cervical visual screening in rural south India. Int J Cancer 2004;109:461-7.
20. Kuhn L, Denny L, Pollack A, Lorincz A, Richart RM, Wright TC. Human papillomavirus testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst 2000;92:818-25.
21. Schiffman M, Herrero R, Hildesheim A, Sherman ME, Bratti M, Wacholder S, Alfaro M, Hutchinson M, Morales J, Greenberg MD, Lorincz AT. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA 2000;283:87-93.
22. Ratnam S, Franco EL, Ferenczy A. Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol Biomarkers Prev 2000;9:945-51.
23. Clavel C, Masure M, Bory JP, Putaud I, Mangeonjean C, Lorenzato M, Nazeyrollas P, Gabriel R, Quereux C, Birembaut P. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer 2001;84: 1616-23.
24. Salmeron J, Lazcano-Ponce E, Lorincz A, Hernández, M, Hernández P, Leyva A, Uribe M, Manzanares H, Antunez A, Carmona E, Ronnett BM, Sherman ME, et al. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico. Cancer Causes Control 2003;14:505-12.
25. Petry K-U, Menton S, Menton M, van Loenen-Frosch F, de Carvalho Gomes H, Holz B, Schopp B, Garbrecht-Buettner, Davies P, Boehmer G, van den Akker E, Iftner T. Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients. Br J Cancer 2003;88:1570-7.
26. Sankaranarayanan R, Chatteiji R, Shastri S, Wesley RS, Basu P, Mahe C, Muwonge R, Seigneurin D, Somanathan T, Roy C, Kelkar R, Chinoy R, et al. Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India. Int J Cancer 2004;112:341-7.
27. Royal Thai College of Obstetricians and Gynaecologists (RTCOG)/ JHPIEGO Corporation Cervical Cancer Prevention Group. Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project. Lancet 2003;361:814-20.